Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy
- PMID: 22754758
- PMCID: PMC3382878
- DOI: 10.4161/onci.20074
Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy
Abstract
Radiotherapy applies ionizing irradiation to selected areas of the body with the scope of destroying cancer cells, either as part of curative therapies to remove a primary malignant tumor and to prevent tumor recurrence after surgery, or as part of palliative measures to avoid local advancement of bone and brain metastases. Intriguingly, radiotherapy does not only have local effects but may lead to the delayed regression of distant non-irradiated lesions. Most likely, these "abscopal" effects are mediated by the immune system.
Similar articles
-
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma.Front Oncol. 2019 Sep 26;9:922. doi: 10.3389/fonc.2019.00922. eCollection 2019. Front Oncol. 2019. PMID: 31616634 Free PMC article.
-
Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.Radiat Oncol. 2019 Jan 29;14(1):21. doi: 10.1186/s13014-019-1227-y. Radiat Oncol. 2019. PMID: 30696472 Free PMC article.
-
Abscopal effect following radiation monotherapy in breast cancer: A case report.Mol Clin Oncol. 2018 Sep;9(3):283-286. doi: 10.3892/mco.2018.1677. Epub 2018 Jul 19. Mol Clin Oncol. 2018. PMID: 30155251 Free PMC article.
-
Immune mechanisms mediating abscopal effects in radioimmunotherapy.Pharmacol Ther. 2019 Apr;196:195-203. doi: 10.1016/j.pharmthera.2018.12.002. Epub 2018 Dec 5. Pharmacol Ther. 2019. PMID: 30529041 Review.
-
Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences.Immunol Rev. 2017 Nov;280(1):249-279. doi: 10.1111/imr.12573. Immunol Rev. 2017. PMID: 29027221 Review.
Cited by
-
Immunotherapeutic strategies to target prognostic and predictive markers of cancer.Biomark Med. 2013 Feb;7(1):23-35. doi: 10.2217/bmm.12.110. Biomark Med. 2013. PMID: 23387482 Free PMC article. Review.
-
The Concept of Hormesis in Cancer Therapy - Is Less More?Cureus. 2015 Apr 2;7(4):e261. doi: 10.7759/cureus.261. eCollection 2015 Apr. Cureus. 2015. PMID: 26180685 Free PMC article. Review.
-
Trial Watch: Chemotherapy with immunogenic cell death inducers.Oncoimmunology. 2014 Jan 1;3(1):e27878. doi: 10.4161/onci.27878. Epub 2014 Mar 1. Oncoimmunology. 2014. PMID: 24800173 Free PMC article. Review.
-
Trial watch: Dendritic cell-based interventions for cancer therapy.Oncoimmunology. 2013 Oct 1;2(10):e25771. doi: 10.4161/onci.25771. Epub 2013 Jul 29. Oncoimmunology. 2013. PMID: 24286020 Free PMC article. Review.
-
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.BMC Cancer. 2014 Oct 6;14:748. doi: 10.1186/1471-2407-14-748. BMC Cancer. 2014. PMID: 25288198 Free PMC article. Clinical Trial.
References
LinkOut - more resources
Full Text Sources